Helus Pharma Inc. (HELP) Form 6-K — Oct 27, 2026
Helus Pharma announced that co-founders Eric So and Paul Glavine have stepped down from their executive and consulting roles, while continuing to serve on the Board of Directors. So had been President and Executive Chairman, and Glavine Chief Growth Officer. The Board appointed Mark Lawson, a director since 2020 and private equity/investment banking executive, as independent Chair effective immediately, and named Eric So Chairman Emeritus. The company framed the move as a transition to its next stage of growth under recently appointed CEO Michael Halstead.
Key figures
- Phase3 data readout
- Q4 2026 topline data from APPROACH study of HLP003 in major depressive disorder
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.